Hubin Timothy J, Amoyaw Prince N-A, Roewe Kimberly D, Simpson Natalie C, Maples Randall D, Carder Freeman TaRynn N, Cain Amy N, Le Justin G, Archibald Stephen J, Khan Shabana I, Tekwani Babu L, Khan M O Faruk
Department of Chemistry, Southwestern Oklahoma State University, 100 Campus Drive, Weatherford, OK 73096, United States.
College of Pharmacy, Southwestern Oklahoma State University, 100 Campus Drive, Weatherford, OK 73096, United States.
Bioorg Med Chem. 2014 Jul 1;22(13):3239-44. doi: 10.1016/j.bmc.2014.05.003. Epub 2014 May 11.
Using transition metals such as manganese(II), iron(II), cobalt(II), nickel(II), copper(II), and zinc(II), several new metal complexes of cross-bridged tetraazamacrocyclic chelators namely, cyclen- and cyclam-analogs with benzyl groups, were synthesized and screened for in vitro antimalarial activity against chloroquine-resistant (W2) and chloroquine-sensitive (D6) strains of Plasmodium falciparum. The metal-free chelators tested showed little or no antimalarial activity. All the metal complexes of the dibenzyl cross-bridged cyclam ligand exhibited potent antimalarial activity. The Mn(2+) complex of this ligand was the most potent with IC50s of 0.127 and 0.157μM against the chloroquine-sensitive (D6) and chloroquine-resistant (W2) P. falciparum strains, respectively. In general, the dibenzyl hydrophobic ligands showed better anti-malarial activity compared to the activity of monobenzyl ligands, potentially because of their higher lipophilicity and thus better cell penetration ability. The higher antimalarial activity displayed by the manganese complex for the cyclam ligand in comparison to that of the cyclen, correlates with the larger pocket of cyclam compared to that of cyclen which produces a more stable complex with the Mn(2+). Few of the Cu(2+) and Fe(2+) complexes also showed improvement in activity but Ni(2+), Co(2+) and Zn(2+) complexes did not show any improvement in activity upon the metal-free ligands for anti-malarial development.
使用锰(II)、铁(II)、钴(II)、镍(II)、铜(II)和锌(II)等过渡金属,合成了几种新的跨桥四氮杂大环螯合剂的金属配合物,即带有苄基的环烯和环胺类似物,并针对恶性疟原虫的氯喹抗性(W2)和氯喹敏感性(D6)菌株进行了体外抗疟活性筛选。所测试的无金属螯合剂显示出很少或没有抗疟活性。二苄基跨桥环胺配体的所有金属配合物均表现出强效抗疟活性。该配体的Mn(2+)配合物最为有效,对氯喹敏感(D6)和氯喹抗性(W2)恶性疟原虫菌株的IC50分别为0.127和0.157μM。一般来说,二苄基疏水配体比单苄基配体表现出更好的抗疟活性,这可能是因为它们具有更高的亲脂性,从而具有更好的细胞穿透能力。与环烯相比,环胺配体的锰配合物表现出更高的抗疟活性,这与环胺比环烯具有更大的口袋有关,环胺与Mn(2+)形成更稳定的配合物。少数Cu(2+)和Fe(2+)配合物的活性也有所提高,但Ni(2+)、Co(2+)和Zn(2+)配合物在抗疟开发方面相对于无金属配体没有表现出活性的提高。